{"id":"ropinirole-xl-formerly-cr","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Dyskinesia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This action helps to increase the levels of dopamine in the brain, which can help to alleviate symptoms of Parkinson's disease. Ropinirole XL is a long-acting formulation of the drug, which allows for once-daily dosing.","oneSentence":"Ropinirole XL is a dopamine agonist that works by stimulating dopamine receptors in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:32:40.241Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of Parkinson's disease"},{"name":"Treatment of restless legs syndrome"}]},"trialDetails":[{"nctId":"NCT00632736","phase":"PHASE3","title":"An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-02","conditions":"Parkinson Disease, Parkinson's Disease","enrollment":419},{"nctId":"NCT00650104","phase":"PHASE3","title":"Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2002-05","conditions":"Parkinson Disease","enrollment":76}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Ropinirole XL (formerly CR)","genericName":"Ropinirole XL (formerly CR)","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ropinirole XL is a dopamine agonist that works by stimulating dopamine receptors in the brain. Used for Treatment of Parkinson's disease, Treatment of restless legs syndrome.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}